Article
Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophrenia.
American journal of medical genetics - 8 Aug 2001
Schulze T G, Schumacher J, Müller D J, Krauss H, Alfter D, Maroldt A, Ahle G, Maroldt A O, Novo y Fernández A, Weber T, Held T, Propping P, Maier W, Nöthen M M, Rietschel M
Abstract excerpt
Tardive dyskinesia (TD) is a common side effect of long-term medication with typical neuroleptics. TD presents itself by abnormal involuntary movements and may lead to a potentially disabling and chronic clinical course. A vast majority of patients suffering from schizophrenia are smokers. Smoking has been reported to induce the activity of the CYP1A2 enzyme, which is an established metabolic pathway within the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
